Tampa General Hospital and Hyro Partner to Transform Call Center Operations With Voice AI Agents
Daily call abandonment fell 56% and average wait times dropped 58% after Hyro's AI agents were introduced to optimize patient...
Neuroscience
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of...
Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted marketing...
BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025
BURLINGTON, Mass. and JERUSALEM, Nov. 25, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update
Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Anavex...
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program
First publicly listed company to actively investigate psilocybin’s potential impact on longevity NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) --...
ProMIS Neurosciences Announces Reverse Stock Split
Cambridge, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for...
AdventHealth Collaborates with Aidoc for One of the Largest Imaging AI Deployments in the U.S.
The collaboration aims to support care coordination and enhance patient safety at AdventHealth. NEW YORK, Nov. 20, 2025 /PRNewswire/ --...
Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs
SAN DIEGO, Nov. 20, 2025 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, today announced the...
Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia
Calgary, Alberta--(Newsfile Corp. - November 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...
Axsome Therapeutics to Participate in Upcoming Investor Conferences
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era...
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025
GT-02287 reduces mitochondrial stress and enhances neuronal survival in MPP+ treated rat dopaminergic neurons GT-02287 decreases staining for MIRO1, suggesting...
Seedtag Releases First-of-Its-Kind Neuroscience Study Redefining Human-Centered Advertising Effectiveness
Brain activity study shows Neuro-Contextual advertising drives 3.5x higher neural engagement and 26% lift in positive, action-driving response NEW YORK,...
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors
BURLINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development...
Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges
Teva Launches Teva Rise Teva Launches Rise - Global Open Innovation Platform First cohort features 7 real-world challenges across R&D,...
Mount Sinai Medical Center Achieves HIMSS EMRAM Stage 7 Validation
South Florida hospital recognized at the highest level of digital care excellence MIAMI BEACH, Fla., Nov. 18, 2025 /PRNewswire/ --...
Linus Health Highlights AI-Enabled Solutions Advancing Early Alzheimer’s Detection and Clinical Trial Readiness at CTAD 2025
BOSTON, Nov. 18, 2025 /PRNewswire/ -- Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and...
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics’ Xenium
Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across...
Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Officer
More than 20 years of financial and operational leadership in biopharma, including $170M+ in capital raised, global commercialization experience, and...
MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor
LA JOLLA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...